クイックアンサー — セルモレリンとは?
Sermorelin is a peptide supplied as a lyophilized powder for reconstitution. The information on this page describes published preclinical and early clinical literature; it is not medical advice or dosing guidance. Read our linked guide for the complete evidence summary.
セルモレリンペプチド
Sermorelin is a synthetic growth hormone–releasing hormone (GHRH 1-29) analog designed for studies involving pituitary function, endocrine regulation, and growth hormone dynamics. It stimulates specific receptors in the anterior pituitary to promote the natural pulsatile release of growth hormone, making it a valuable compound for studying physiological GH signaling patterns. Study models utilize Sermorelin to investigate pathways related to protein synthesis, metabolic balance, tissue repair mechanisms, and age-associated changes in hormonal output. Its targeted receptor activity provides a controlled framework for examining hypothalamic-pituitary interactions, anabolic signaling, and regulatory processes governing growth hormone secretion in clinical environments.
製品概要
Sermorelin is a synthetic peptide classified as a truncated growth hormone–releasing hormone (GHRH 1-29) analog developed for clinical investigation. The Sermorelin peptide has the molecular formula C149H246N44O42S and a molar mass of 3357.9 g/mol, reflecting its precise amino acid sequence engineered for receptor-binding specificity. This lyophilized Sermorelin is supplied as a white, high purity lyophilized form in sterile vials containing 2 mg, 5 mg, or 10 mg of total active ingredient. Image alt text: lyophilized Sermorelin peptide vial 5mg high purity compound. Designed for stability under controlled storage conditions, the compound maintains integrity for up to 36 months when stored properly.
Published Evidence
Sermorelin is widely utilized in studies examining hypothalamic-pituitary signaling pathways and endocrine response modulation. In vitro studies often explore receptor interaction kinetics and downstream intracellular signaling cascades associated with growth hormone regulation. Pre-clinical models apply the Sermorelin peptide to evaluate pulsatile hormone release patterns under controlled clinical conditions. Users also investigate its role in anabolic signaling pathways and protein expression markers. Lyophilized Sermorelin provides consistency for comparative clinical investigation involving endocrine system dynamics. Its defined amino acid structure makes it suitable for mechanistic studies requiring reproducible receptor-binding analysis.
再構成と取り扱い
Lyophilized Sermorelin should be reconstituted using bacteriostatic water under strict aseptic technique within a controlled clinical environment. The diluent should be injected slowly along the inner vial wall to minimize peptide destabilization. Avoid shaking the vial; instead, gently swirl until the powder fully dissolves. Proper handling techniques are essential to maintain structural stability and experimental reliability. After reconstitution, the Sermorelin peptide solution should be refrigerated at 2–8°C and protected from light. All handling procedures should follow standard clinical practice.
作用機序
Sermorelin functions as a selective agonist of growth hormone–releasing hormone receptors located in the anterior pituitary in experimental models. Upon receptor binding, the Sermorelin peptide activates intracellular signaling pathways associated with cyclic AMP production and regulated hormone secretion. Clinical data suggest that this receptor interaction supports pulsatile signaling dynamics relevant to endocrine studies. The molecular structure of Sermorelin allows targeted engagement without broader receptor cross-reactivity in controlled environments. Investigators utilize lyophilized Sermorelin to study feedback loops between hypothalamic and pituitary systems. These mechanisms make it valuable for analyzing regulatory hormone cascade responses in pre-clinical models.
用法・用量ガイドライン
Dosing ranges reported in published experimental literature vary depending on model design and study objectives. Typical in vitro concentrations are calibrated to assess receptor-binding affinity and signal amplification metrics. In pre-clinical models, dosing parameters are adjusted based on body mass equivalents and endocrine response endpoints. Sermorelin should be measured using calibrated clinical instruments to ensure reproducibility. Protocols must be determined by qualified users following institutional guidelines and regulatory compliance standards.
Potential Benefits
- 成長ホルモン受容体相互作用マーカーの評価
- 内分泌シグナル伝達カスケード応答の観察
- タンパク質合成経路指標の分析
- 模擬生体環境における安定性評価
- 視床下部-下垂体フィードバック機構の調査
実験的観察
Experimental investigations of the Sermorelin peptide frequently document measurable activation of pituitary receptor pathways in vitro studies. Users report consistent structural stability of lyophilized Sermorelin under recommended clinical storage conditions. Observational models indicate reproducible signaling amplification responses when applied in controlled concentrations. Sermorelin has demonstrated predictable binding affinity in receptor-focused assays. Clinical findings support its utility in examining regulated endocrine pulsatility without continuous stimulation effects. These observations contribute to a broader understanding of peptide-mediated hormonal regulation mechanisms.
Considerations
Users working with Sermorelin peptide should ensure precise environmental controls to prevent degradation or contamination. Batch consistency and validated sourcing are critical for experimental reliability. Lyophilized Sermorelin should only be handled by trained clinical personnel familiar with peptide studies standards. Analytical verification methods such as chromatography or spectrometry may be employed for identity confirmation when required. Institutional approvals and ethical guidelines must be observed during all investigations. Sermorelin must remain within designated clinical settings at all times. Proper clinical protective equipment should be worn during handling and preparation. Avoid inhalation, ingestion, or direct contact with skin and eyes. All waste materials must be disposed of according to institutional biosafety regulations. Users are responsible for compliance with local and international clinical standards. The information provided is for educational and scientific reference and should not be interpreted as medical advice or as a recommendation for any form of administration. Users should follow all applicable regulations and institutional guidelines when handling this material.
保管方法
For long-term storage, Sermorelin peptide should be kept at −20°C to preserve structural integrity. Short-term storage may be maintained at 2–8°C under refrigeration. Protect lyophilized Sermorelin from direct light exposure to prevent degradation. Avoid repeated freeze-thaw cycles, as they may compromise peptide stability. When stored under recommended conditions, the shelf life is 36 months. Proper storage ensures Sermorelin for studies retains consistency across clinical investigations.
純度と品質
All Sermorelin vials stocked by MedsBase are supplied at 99%+ HPLC purity in lyophilized form. A certificate of analysis (COA) is available on request — message our support team after placing your order and we will forward the batch-specific COA for the vials you received. It is sold. Some peptides in this class have been used in early-phase clinical trials but no major regulator has issued a marketing authorization for the indications discussed in the popular literature.
セルモレリンはどのように再溶解しますか?
凍結乾燥ペプチドは通常、計画した用量に適した濃度で、注射用静菌水または注射用滅菌水(BWFI/SWFI)を用いて溶解します。希釈液はバイアルの内壁に沿ってゆっくりと加えてください。粉末の塊に直接水流を当てたり、激しく振ったりしないでください。いずれもペプチドを変性させます。完全に溶解するまで静かに旋回させてください。再構成後のペプチドは通常、2~8°Cで冷蔵保管します。
セルモレリンはどのように保管すべきですか?
凍結乾燥バイアルは、直射日光を避け、−20°Cまたは2~8°Cの冷蔵で保管すると長期間安定です。再構成後、ほとんどのペプチドは緩衝液や特定のペプチドによりますが、冷蔵で14~30日間安定です。バイアルに同梱されている分析証明書を必ず読み、供給元が推奨する保管および安定性データを確認してください。
What does the published literature shows?
The published literature on Sermorelin is summarized in our linked guide. We separate preclinical (rodent / cell-culture) data, where it is consistent and reproducible, from clinical-trial data, where evidence is typically thinner. We also flag where popular online claims outrun the published record.
セルモレリンを国際的に注文することは合法ですか?
Peptides occupy an ambiguous regulatory space. Importation rules vary by country and have changed in several jurisdictions over the past few years. It is the buyer’s responsibility to confirm import legality in their destination country before ordering. MedsBase ships peptides worldwide via our dedicated peptide courier; orders that contravene the destination country’s import rules may be detained at customs.
セルモレリンの半減期はどのくらいですか?
Sermorelin has a plasma half-life of approximately 10–20 minutes following subcutaneous administration, reflecting rapid enzymatic degradation of the GHRH(1-29) fragment. This brief half-life drives the multiple-daily or pre-sleep dosing schedules typically used in sermorelin protocols.
セルモレリンはCJC-1295とどのように異なりますか?
Both are GHRH analogs, but CJC-1295 (particularly the DAC form) has a substantially longer half-life due to albumin-binding modifications — up to 8 days versus Sermorelin’s ~15 minutes. Sermorelin produces a more physiological, pulsatile GH release pattern in preclinical studies, while CJC-1295 with DAC generates a sustained, blunted GH elevation. Sermorelin is the closer analog to endogenous GHRH physiology.
Sermorelin(セルモレリン)を他のペプチドと一緒に注文できますか?
Yes. Peptide orders are bundled and ship together via our peptide-only courier service. Lyophilized vials are protective for the duration of standard international transit. See our peptide category page for the full stocked range and the “Best Peptides for Recovery” comparison guide for stacking considerations from the published literature.
SermorelinのGH軸刺激は、ランナー、リフター、軟部組織損傷から回復中のアスリートのために、局所的な組織修復ペプチドと併用されることが多くあります。当店の ペプチド ヒーリング スタック (BPC-157 5 mg + TB-500 5 mg) そのレジメンの腱・靭帯の直接修復面をカバーしています。
Other Peptides for Recovery and Performance
- BPC-157 — Body Protection Compound — tendon, ligament, gut recovery
- TB-500 — Thymosin Beta-4 fragment — soft tissue and vascular recovery
- Ipamorelin — 選択的グレリン作動薬 — コルチゾール/プロラクチンを伴わないクリーンなGHパルス
- CJC-1295 with DAC — 半減期延長型GHRHアナログ
- GHK-Cu — Copper peptide — skin and connective tissue regeneration
参考文献
📖 Learn the science behind this peptide
エビデンスに基づく完全ガイドをお読みください: Sermorelin — 用量、副作用、そして誠実な科学. Covers mechanism of action, published study data, typical dosing ranges, reconstitution protocols, stacking considerations, and safety/contraindication notes.
📦 すべてのご注文は、当店の 再発送保証ポリシー — 万が一、20営業日以内に商品が届かない場合は、再発送いたします。
| 仕様 | 詳細 |
|---|---|
| CAS番号 | 86168-78-7 |
| 分子式 | C149H246N44O42S |
| 分子量 | 3357.93 Da |
| 配列 | Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 (GRF 1–29) |
| 形態 | 凍結乾燥粉末(または供給時の形態) |
| 純度 | ≥99%(HPLC検証済み、COAはご要望に応じて提供) |
| 保管方法 | 凍結乾燥品:使用時在庫は2~8℃(冷蔵)に保管。未開封バイアルの長期保管には−20℃。再溶解後:2~8℃で約30日以内に使用。光から保護してください。再溶解液の凍結融解は避けてください。 |
| 溶解性 | 静菌水(推奨)または短時間使用の場合は滅菌水 |















レビュー
まだレビューはありません